News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,946 Results
Type
Article (41347)
Company Profile (266)
Press Release (688316)
Multimedia
Podcasts (91)
Webinars (20)
Section
Business (204857)
Career Advice (2036)
Deals (35581)
Drug Delivery (128)
Drug Development (81505)
Employer Resources (173)
FDA (16502)
Job Trends (14984)
News (346826)
Policy (32752)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2593)
Accelerated approval (45)
Adcomms (26)
Allergies (170)
Alliances (49585)
ALS (207)
Alzheimer's disease (1778)
Antibody-drug conjugate (ADC) (434)
Approvals (16872)
Artificial intelligence (646)
Autoimmune disease (276)
Automation (54)
Bankruptcy (362)
Best Places to Work (11639)
BIOSECURE Act (20)
Biosimilars (219)
Biotechnology (176)
Bladder cancer (186)
Brain cancer (70)
Breast cancer (742)
Cancer (5734)
Cardiovascular disease (463)
Career advice (1727)
Career pathing (41)
CAR-T (320)
CDC (56)
Celiac Disease (3)
Cell therapy (865)
Cervical cancer (46)
Clinical research (70695)
Collaboration (2023)
Company closure (5)
Compensation (1379)
Complete response letters (78)
COVID-19 (2739)
CRISPR (107)
C-suite (1096)
Cystic fibrosis (150)
Data (7689)
Decentralized trials (3)
Denatured (27)
Depression (158)
Dermatology (82)
Diabetes (581)
Diagnostics (6911)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (313)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (280)
Earnings (91809)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119257)
Executive appointments (1073)
FDA (20170)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1701)
Gene editing (230)
Generative AI (55)
Gene therapy (700)
GLP-1 (1047)
Government (4726)
Grass and pollen (6)
Guidances (408)
Healthcare (18988)
HIV (79)
Huntington's disease (56)
IgA nephropathy (96)
Immunology and inflammation (284)
Immuno-oncology (88)
Indications (185)
Infectious disease (3075)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (288)
Interviews (320)
IPO (16665)
IRA (50)
Job creations (3648)
Job search strategy (1434)
JPM (58)
Kidney cancer (19)
Labor market (98)
Layoffs (561)
Leadership (38)
Legal (7954)
Liver cancer (99)
Longevity (32)
Lung cancer (754)
Lymphoma (424)
Machine learning (59)
Management (59)
Manufacturing (1017)
MASH (183)
Medical device (13917)
Medtech (14027)
Mergers & acquisitions (20153)
Metabolic disorders (1478)
mRNA (198)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (406)
Neuropsychiatric disorders (104)
Neuroscience (3265)
Neurotech (1)
NextGen: Class of 2026 (6522)
Non-profit (4533)
Now hiring (77)
Obesity (692)
Opinion (285)
Ovarian cancer (216)
Pain (250)
Pancreatic cancer (294)
Parkinson's disease (353)
Partnered (33)
Patents (590)
Patient recruitment (659)
Peanut (62)
People (59542)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22031)
Phase 2 (31146)
Phase 3 (23181)
Pipeline (8295)
Policy (312)
Postmarket research (2568)
Preclinical (9377)
Press Release (64)
Prostate cancer (292)
Psychedelics (54)
Radiopharmaceuticals (319)
Rare diseases (1053)
Real estate (5969)
Recruiting (70)
Regulatory (25329)
Reports (56)
Research institute (2413)
Resumes & cover letters (353)
Rett syndrome (36)
RNA editing (20)
RSV (88)
Schizophrenia (176)
Series A (287)
Series B (210)
Service/supplier (11)
Sickle cell disease (110)
Special edition (23)
Spinal muscular atrophy (165)
Sponsored (48)
Startups (3638)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (62)
Vaccines (1085)
Venture capital (107)
Weight loss (444)
Women's health (122)
Worklife (20)
Date
Today (45)
Last 7 days (946)
Last 30 days (3110)
Last 365 days (30099)
2026 (11597)
2025 (30172)
2024 (35212)
2023 (40074)
2022 (51176)
2021 (55714)
2020 (54083)
2019 (46540)
2018 (35021)
2017 (32111)
2016 (31485)
2015 (37558)
2014 (31324)
2013 (26355)
2012 (28574)
2011 (29267)
2010 (27334)
Location
Africa (742)
Alabama (91)
Alaska (7)
Arizona (345)
Arkansas (14)
Asia (39635)
Australia (6498)
California (13052)
Canada (3712)
China (1314)
Colorado (558)
Connecticut (566)
Delaware (398)
Europe (85749)
Florida (1954)
Georgia (419)
Hawaii (3)
Idaho (62)
Illinois (1039)
India (88)
Indiana (593)
Iowa (23)
Japan (526)
Kansas (130)
Kentucky (50)
Louisiana (40)
Maine (75)
Maryland (1568)
Massachusetts (9299)
Michigan (358)
Minnesota (704)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (140)
New Hampshire (84)
New Jersey (3438)
New Mexico (29)
New York (3412)
North Carolina (1654)
North Dakota (8)
Northern California (6524)
Ohio (388)
Oklahoma (23)
Oregon (41)
Pennsylvania (2628)
Puerto Rico (29)
Rhode Island (50)
South America (1113)
South Carolina (85)
South Dakota (2)
Southern California (5150)
Tennessee (209)
Texas (2066)
United States (46051)
Utah (391)
Vermont (1)
Virginia (311)
Washington D.C. (80)
Washington State (1049)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
729,946 Results for "biosense webster inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO™ 3 System Version 8, the latest version of the company’s leading three-dimension heart mapping system used in cardiac ablation procedures.
May 8, 2024
·
8 min read
Biotech Beach
Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE™ Platform for the Treatment of Paroxysmal Atrial Fibrillation
Biosense Webster, Inc. announced the submission of the VARIPULSE™ Platform for Premarket Approval Application (PMA) to the U.S. Food & Drug Administration (FDA).
March 25, 2024
·
8 min read
Biotech Beach
Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced late-breaking results from the pivotal phase of the admIRE pivotal clinical trial, plus additional results from the VIRTUE study, presented at the Heart Rhythm Society (HRS) Annual Meeting in Boston from May 16-19.
May 17, 2024
·
12 min read
Biotech Beach
Biosense Webster Announces Regulatory Approval of VARIPULSE™ Pulsed Field Ablation (PFA) Platform in Japan
Biosense Webster, Inc. today announced approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the VARIPULSE™ Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AFib) using pulsed field ablation (PFA).
January 9, 2024
·
7 min read
Biotech Beach
Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced the U.S. launch of the OPTRELL™ Mapping Catheter with TRUEref™ Technology powered by the CARTO® 3 System.
July 24, 2023
·
8 min read
Press Releases
Xsensio SA Raises $7M Oversubscribed Series A, Accelerates Clinical Deployment of Continuous Biosensing
March 2, 2026
·
2 min read
FDA
Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced that several products in its market-leading cardiac ablation portfolio have received approval for a zero fluoroscopy workflow from the U.S. Food and Drug Administration (FDA).
August 4, 2023
·
8 min read
Biotech Beach
Biosense Webster, Inc. to Highlight Latest Innovations at AF Symposium 2023 Showcasing Breadth of Cardiac Rhythm Portfolio
Biosense Webster, Inc. announced that data from five company-sponsored studies, including two late breakers, will be presented at the 28th Annual International AF Symposium in Boston from February 2–4.
January 23, 2023
·
7 min read
Biotech Beach
New Data Published on Biosense Webster QDOT MICRO™ Catheter - the Latest Advancement in Focal RF Ablation for Treating AFib
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced that data from the Q-FFICIENCY study was published in JACC: Clinical Electrophysiology.
May 15, 2023
·
9 min read
Biotech Beach
New Biosense Webster QDOT MICRO™ Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib Patients
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced new findings from the Q-FFICIENCY study were published in the Journal of Cardiovascular Electrophysiology demonstrating treatment with the QDOT MICRO™ Catheter significantly improved control of atrial fibrillation, relief of symptoms and overall quality of life.
November 2, 2023
·
10 min read
1 of 72,995
Next
